Gabriel Di Gresia

Gabriel Di Gresia

Auto-generated profile, based on publicly available information

Gabriel Di Gresia

Instituto de Química Rosario (IQUIR-CONICET-UNR), Suipacha 531, S2002LRK, Rosario, Argentina

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2022 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
RCRenzo Carlucci
Renzo Carlucci
GGGabriel Di Gresia
Gabriel Di Gresia
MMMaría Gabriela Mediavilla
María Gabriela Mediavilla
JCJulia Alejandra Cricco
Julia Alejandra Cricco
BTBabu L. Tekwani
Babu L. Tekwani
GLGuillermo Roberto Labadie
Guillermo Roberto Labadie
We have previously shown that prenyl and aliphatic triazoles are interesting motifs to prepare new chemical entities for antiparasitic and antituberculosis drug development. In this opportunity a new series of prenyl-1,2,3-triazoles were prepared from isoprenyl azides and different alkynes looking for new antimalarial drug candidates. The compounds were prepared by copper(I) catalyzed dipolar cycloaddition of the isoprenyl azide equilibrium mixture providing exclusively 1,4-disubstituted 1,2,3-triazoles in a regiospecific fashion. The complete collection of 64 compounds was tested on chloroquine-sensitive (CQ sensitive), Sierra Leone (D6), and the chloroquine-resistant, Indochina (W2), strains of Plasmodium falciparum and those compounds which were not previously reported were also tested against Leishmania donovani, the causative agent for visceral leishmaniasis. Thirteen analogs displayed antimalarial activity with IC50 below 10 μM, while the antileishmanial activity of the newly reported analogs could not improve upon those previously reported. Compounds 1o and 1r were identified as the most promising antimalarial drug leads with IC50 below 3.0 μM for both CQ-sensitive and resistant P. falciparum strains with high selectivity index. Finally, a chemoinformatic in silico analysis was performed to evaluate physicochemical parameters, cytotoxicity risk and drug score. The validation of a bifunctional farnesyl/geranylgeranyl diphosphate synthase PfFPPS/GGPPS as the potential target of the antimalarial activity of selected analogs should be further investigated.

1 January 2026 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
ARAlejandro I. Recio-Balsells
Alejandro I. Recio-Balsells
GGGabriel Di Gresia
Gabriel Di Gresia
MMMarcelo Luciano Merli
Marcelo Luciano Merli
JCJulia Alejandra Cricco
Julia Alejandra Cricco
HMHector R. Morbidoni
Hector R. Morbidoni
GLGuillermo Roberto Labadie
Guillermo Roberto Labadie
The emergence of drug-resistant Mycobacterium tuberculosis strains and non-tuberculous mycobacteria (NTM) species such as Mycobacterium abscessus, highlights the urgent need for new chemotypes with broad-spectrum antimycobacterial activity. In this study,...